Applied AI. Deep expertise. Better commercial decisions.
MethodsSignals is the first commercial intelligence offering introduced by the ChannelM Group.
Built to replace commercial intelligence chaos with clear action.
MethodsSignals is the first commercial intelligence offering introduced by the ChannelM Group.
Its foundation is a proprietary database developed through Channel Methods’ business development programs and refined over more than 20 years of creating qualified opportunities across the life sciences industry.
MethodsSignals combines that intelligence with applied AI infrastructure and InsightOps human-in-the-loop expertise to create a commercial capability that goes beyond conventional data platforms. The result is intelligence shaped by real-world selling experience, proprietary market knowledge, and a deep understanding of how life sciences organizations evaluate and purchase specialized services.
Recreating what MehtodsSignals delivers would require multiple separate subscriptions for market intelligence, account identification, and contact data, the costs of which can quickly exceed $100,000. Meanwhile the salespeople are still left to validate the data, connect the signals, and decide where to focus.
The rapid growth of AI-generated outreach has made the problem worse. Buyers are being inundated with generic messages that lack relevance, timing, and commercial context.
Building AI-enabled commercial solutions from decades of sales experience.
ChannelM Group is a holding company created to develop and scale commercial solutions that combine applied AI, proprietary intelligence, and proven sales expertise.
Its first company, MethodsSignals, brings that model to life sciences by helping commercial teams turn fragmented market data into actionable opportunities.
ChannelM Group will initially focus on life sciences before expanding across other FDA-regulated industries where complex markets and high-value buying decisions demand better intelligence and execution.
- 1The ConsultancyChannel MCommercial Growth Consultancy
Develops commercial intelligence, artificial intelligence, data-driven business solutions, and intellectual property that help organizations make better strategic and commercial decisions.
- 2The Flagship PlatformMethodsSignals™AI-Enabled Commercial Intelligence Platform
The flagship commercial intelligence system developed by Channel M — purpose-built for life sciences and delivered as an extension of your commercial strategy.
- 3The OutcomeExecutive Growth OutcomesMeasurable Commercial Performance
Earlier opportunity identification, sharper prioritization, stronger pipeline visibility, and improved commercial decisions across life science leadership teams.
Why MethodsSignals exists — and where it's going.
To help life science organizations identify opportunities earlier, prioritize resources more effectively, and make better commercial decisions through intelligence-driven insight.
MethodsSignals was developed for the life sciences industry with the vision of transforming how organizations discover opportunities, evaluate markets, and make commercial decisions.
As the company evolves, MethodsSignals intends to expand its commercial intelligence model into additional industries where market insight, timing, and decision quality create meaningful competitive advantage.